In general, whole virus inactivated adjuvanted vaccines for other infectious diseases predominantly generate low to moderate short-lived antigen specific CD4+ T helper cells but are less efficient compared to MLV in inducing CD8+ functional T cells [33]. Here, CD4 is linked to infectious disease.